Stacy Price
Technik-/Wissenschafts-/F&E-Leiter bei INVIVYD, INC.
Vermögen: - $ am 31.05.2024
Aktive Positionen von Stacy Price
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| INVIVYD, INC. | Technik-/Wissenschafts-/F&E-Leiter | 01.03.2023 | - |
Karriereverlauf von Stacy Price
Ehemalige bekannte Positionen von Stacy Price
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| AKOUOS | Technik-/Wissenschafts-/F&E-Leiter | 01.11.2021 | - |
| ALAUNOS THERAPEUTICS, INC. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
Ausbildung von Stacy Price
| Tufts University | Graduate Degree |
Statistik
International
| Vereinigte Staaten | 5 |
Operativ
| Chief Tech/Sci/R&D Officer | 3 |
| Graduate Degree | 1 |
| Undergraduate Degree | 1 |
Sektoral
| Health Technology | 4 |
| Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| ALAUNOS THERAPEUTICS, INC. | Health Technology |
| INVIVYD, INC. | Health Technology |
| Private Unternehmen | 1 |
|---|---|
Akouos, Inc.
 Akouos, Inc. BiotechnologyHealth Technology Akouos, Inc. is a precision genetic medicine company, which engages in the development of precision genetic medicines to restore and preserve hearing in genetically-defined patient populations. The firm's lead product candidate, AK-OTOF, is a gene therapy for the treatment of hearing loss due to mutations in the OTOF gene. It develops targeted adeno-associated viral vector based gene therapies for sensorineural hearing loss, which results from dysfunction or damage to sensory cells and nerve fibers of the inner ear. The company was founded by Emmanuel J. Simons, William F. Sewell, Richard H. Smith, Luk H. Vandenberghe, and Michael J. McKenna on March 7, 2016 and is headquartered in Boston, MA. | Health Technology |
- Börse
- Insiders
- Stacy Price
- Erfahrung
